These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7627143)

  • 21. Pharmacokinetics of amphotericin B in rats as a function of dose following constant-rate intravenous infusion.
    Chow HH; Wu Y; Mayersohn M
    Biopharm Drug Dispos; 1995 Aug; 16(6):461-73. PubMed ID: 7579028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.
    Alvarez-Lerma F; Soriano MC; Rodríguez M; Catalán M; Llorente AM; Vidart N; Garitacelaya M; Maraví E; Fernández E; Alvarado F; López M; Alvarez-Sánchez B; Espinosa J; Quintana E;
    Rev Esp Quimioter; 2012 Sep; 25(3):206-15. PubMed ID: 22987267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact on renal function of an early switch from conventional to liposomal amphotericin B formulation in the empirical treatment of fungal infections].
    Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Monchecourt F; Mahi L; Deray G
    Med Mal Infect; 2008 Apr; 38(4):208-14. PubMed ID: 18191521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats.
    Zhang Z; Diener RM; Lipman JM
    Int J Toxicol; 2006; 25(4):285-94. PubMed ID: 16815817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of glomerular filtration rate by the 99mTc-DTPA renogram is less precise than measured and predicted creatinine clearance.
    De Santo NG; Anastasio P; Cirillo M; Santoro D; Spitali L; Mansi L; Celentano L; Capodicasa D; Cirillo E; Del Vecchio E; Pascale C; Capasso G
    Nephron; 1999 Feb; 81(2):136-40. PubMed ID: 9933747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
    Joly V; Dromer F; Barge J; Yeni P; Seta N; Molas G; Carbon C
    J Pharmacol Exp Ther; 1989 Oct; 251(1):311-6. PubMed ID: 2795463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis.
    López-Sánchez A; Pérez-Cantero A; Torrado-Salmerón C; Martin-Vicente A; García-Herrero V; González-Nicolás MÁ; Lázaro A; Tejedor A; Torrado-Santiago S; García-Rodríguez JJ; Capilla J; Torrado S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal impairment and amphotericin B formulations in patients with invasive fungal infections.
    Saliba F; Dupont B
    Med Mycol; 2008 Mar; 46(2):97-112. PubMed ID: 18324488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis contributes to amphotericin B-induced nephrotoxicity.
    Varlam DE; Siddiq MM; Parton LA; Rüssmann H
    Antimicrob Agents Chemother; 2001 Mar; 45(3):679-85. PubMed ID: 11181342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of serum iohexol clearance for use in predicting carboplatin clearance in cats.
    Bailey DB; Rassnick KM; Prey JD; Dykes NL
    Am J Vet Res; 2009 Sep; 70(9):1135-40. PubMed ID: 19719430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication.
    Oto OA; Paydas S; Disel U; Yavuz S; Seydaoglu G
    Mycoses; 2007 Mar; 50(2):135-9. PubMed ID: 17305778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radionuclide method for evaluating the performance of hemodialysis in vivo.
    Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM
    Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of an experimental Fanconi syndrome in mice: its effect on the glomerular filtration function studied by 99mTc-DTPA.
    Sawas-Dimopoulou C; Sigalas I; Margaritis L
    Nucl Med Biol; 1996 Aug; 23(6):807-12. PubMed ID: 8940724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the aggregation state of amphotericin B on its toxicity to mice.
    Barwicz J; Christian S; Gruda I
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2310-5. PubMed ID: 1444311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs.
    Nieto J; Alvar J; Rodríguez C; San Andrés MI; San Andrés MD; González F
    Res Vet Sci; 2018 Apr; 117():125-132. PubMed ID: 29272720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate.
    Pai MP; Norenberg JP; Telepak RA; Sidney DS; Yang S
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3784-8. PubMed ID: 16127053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
    Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
    Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
    Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
    J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turning weakness into strength: Albumin nanoparticle-redirected amphotericin B biodistribution for reducing nephrotoxicity and enhancing antifungal activity.
    Liu Y; Han Y; Fang T; Chen SM; Hu X; Song L; Shen H; Dong H; Jiang YY; Zou Z; Li Y; An MM
    J Control Release; 2020 Aug; 324():657-668. PubMed ID: 32446873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.